You have 9 free searches left this month | for more free features.

HIV-1

Showing 9976 - 10000 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Improving Primacy Care Access to Urinary Incontinence Treatment

Not yet recruiting
  • Urinary Incontinence
  • Mobile Health Application focused on behavioral treatments to treat urinary incontinence
  • Practice Facilitation
  • Birmingham, Alabama
  • +1 more
Jul 19, 2022

PTSD Trial (Prolonged Exposure Therapy for Posttraumatic Stress Disorder)

Not yet recruiting
  • Posttraumatic Stress Disorder
  • Prolonged Exposure Therapy for Posttraumatic Stress Disorder
  • (no location specified)
Dec 22, 2022

Dry Eye, Glaucoma Trial in Madrid (Insulin, Artificial tear)

Recruiting
  • Dry Eye
  • Glaucoma
  • Madrid, Spain
    Hospital Clinico San Carlos
Sep 1, 2023

Heart Arrest, Birth Asphyxia, Bradycardia Trial in Austria, Canada (CC+SI, 3:1 C:V)

Recruiting
  • Heart Arrest
  • +2 more
  • CC+SI
  • 3:1 C:V
  • Graz, Austria
  • +3 more
Jun 9, 2022

Prostate Cancer Trial in Worldwide (ODM-201, ADT)

Active, not recruiting
  • Prostate Cancer
  • Brussels, Belgium
  • +11 more
Jun 9, 2022

Understanding RSV: Severe Disease and the Long Term Consequences

Active, not recruiting
  • Respiratory Syncytial Virus (RSV)
  • RSV point of care testing
  • Oxford, United Kingdom
  • +1 more
Jan 28, 2022

Gestational Diabetes, Preventive Care / Anticipatory Guidance, Retention in Care Trial in Chicago (Patient Navigation Program)

Active, not recruiting
  • Gestational Diabetes
  • +4 more
  • Patient Navigation Program
  • Chicago, Illinois
    Northwestern Memorial Hospital
Oct 7, 2022

Malignant Melanoma, Liver Metastases Trial (Recombinant Human Adenovirus Type 5 Injection,Camrelizumab,Nab-paclitaxel)

Not yet recruiting
  • Malignant Melanoma
  • Liver Metastases
  • Recombinant Human Adenovirus Type 5 Injection,Camrelizumab,Nab-paclitaxel
  • (no location specified)
Dec 23, 2022

Homocystinuria Trial in High Point (SYNB1353)

Recruiting
  • Homocystinuria
  • High Point, North Carolina
    High Point Clinical Trials Center
Jul 13, 2022

Pancreatitis, Chronic, Exocrine Pancreatic Insufficiency, Abdominal Pain Trial in Shanghai (extracorporeal shock wave

Recruiting
  • Pancreatitis, Chronic
  • +3 more
  • extracorporeal shock wave lithotripsy and endoscopic drainage of the main pancreatic duct
  • pancreatic enzyme(Pancreatin Enteric-coated Capsules or Oryz-Aspergillus Enzyme and Pancreatin Table), antidiabetic medicine(Acarbose Tablets, Glucophage, Glimepirde Tablets)
  • Shanghai, China
    Changhai Hospital
Feb 26, 2022

MYFEMBREE®: A Retrospective Cohort Study UsingAdministrative

Not yet recruiting
  • Pregnancy Related
  • +2 more
  • Relugolix + Estradiol + Norethindrone Acetate
  • (no location specified)
Feb 13, 2023

Prostate Cancer, Breast Cancer Female Trial in Tomsk (whole body study and SPECT with 99mTc-RM26)

Enrolling by invitation
  • Prostate Cancer
  • Breast Cancer Female
  • whole body study and SPECT with 99mTc-RM26
  • Tomsk, Russian Federation
    TomskNRMC
Jul 4, 2022

Type I IFN Level and Disease Activity in SLE Patients

Not yet recruiting
  • Elevated Level of IFN Type I in SLE Patients
  • study of IFNGS expression biomarkers
  • (no location specified)
Jun 30, 2022

Congenital Hypothyroidism Trial in United States (Tirosint®-SOL, Levothyroxine Sodium)

Recruiting
  • Congenital Hypothyroidism
  • Los Angeles, California
  • +10 more
Oct 7, 2022

Severe Aplastic Anemia Trial in Atlanta (Fludarabine, Cyclophosphamide, Total Body Irradiation)

Recruiting
  • Severe Aplastic Anemia
  • Atlanta, Georgia
  • +1 more
Apr 4, 2022

Emotion Regulation, Self Efficacy, Acceptability of Health Care Trial (Dialectical Behavior Therapy skills video intervention)

Not yet recruiting
  • Emotion Regulation
  • +2 more
  • Dialectical Behavior Therapy skills video intervention
  • (no location specified)
Sep 3, 2023

Hearing Loss, Sensorineural, Hearing Loss, Bilateral Trial in United States (Cochlear implantation)

Terminated
  • Hearing Loss, Sensorineural
  • Hearing Loss, Bilateral
  • Cochlear implantation
  • Tucson, Arizona
  • +7 more
Oct 13, 2021

Glomerulonephritis, IGA, Kidney Diseases, Acute Renal Insufficiency Trial in Beijing (Plasma Exchange (PE), Methylprednisolone

Terminated
  • Glomerulonephritis, IGA
  • +3 more
  • Plasma Exchange (PE)
  • Methylprednisolone pulse
  • Beijing, Beijing, China
  • +1 more
Sep 30, 2021

Dermatomyositis Trial in Paris (Baricitinib, Placebo)

Not yet recruiting
  • Dermatomyositis
  • Paris, France
    Pitie-Salpêtrière hospital APHP
Jun 7, 2022

Amyotrophic Lateral Sclerosis, ALS, Lou Gehrig Disease Trial in United States (BHV-0223)

Completed
  • Amyotrophic Lateral Sclerosis
  • +5 more
  • Fort Lauderdale, Florida
  • +4 more
Feb 28, 2022

Hodgkin Disease, Lymphoma, Non-Hodgkin, Lymphoma, B-Cell Trial in Worldwide (pembrolizumab, Favezelimab)

Recruiting
  • Hodgkin Disease
  • +2 more
  • pembrolizumab
  • Favezelimab
  • Gilbert, Arizona
  • +24 more
Aug 18, 2022

Pain, Acute, Postoperative Pain, Analgesia Trial in San Carlos (Bupivacaine-Lidocaine, Bupivacaine)

Not yet recruiting
  • Pain, Acute
  • +2 more
  • San Carlos, Ñuble, Chile
    Hospital de San Carlos Dr. Benicio Arzola Medina
Apr 18, 2023

Cervix Cancer, Cervical Cancer, Cancer of the Uterine Cervix Trial in Varanasi (Neoadjuvant chemo)

Completed
  • Cervix Cancer
  • +2 more
  • Neoadjuvant chemotherapy
  • Varanasi, UP, India
    Banaras Hindu University
May 19, 2022

Swallowing Disorder, Sarcopanic Dysphagia Trial in Lyon (EAT-10 (Eating assessment Tool) screening questionnaire, Protective

Not yet recruiting
  • Swallowing Disorder
  • Sarcopanic Dysphagia
  • EAT-10 (Eating assessment Tool) screening questionnaire
  • Protective measures for the upper airways
  • Lyon, France
    Centre Hospitalier Lyon Sud - Court Séjour Gériatrique
Feb 8, 2023

Endometrial Tumors, Ovarian Cancer, Solid Tumor Trial in United States (COM701 in combination with BMS-986207 and nivolumab.)

Recruiting
  • Endometrial Neoplasms
  • +3 more
  • COM701 in combination with BMS-986207 and nivolumab.
  • Chicago, Illinois
  • +8 more
Aug 8, 2022